COMMUNIQUÉS West-GlobeNewswire

NMDP Surpasses $100 Million Comprehensive Campaign Goal to Expand Patient Access, Remove Financial Barriers to Life-saving Transplants
01/10/2025
The announcement, made at the 18th annual NMDP Gala in Minneapolis, represents significant philanthropic support of the organization’s mission to save lives through cell therapy MINNEAPOLIS, Sept. 30, 2025 (GLOBE [...]
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
01/10/2025
Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional payments for other indications; includes contingent R&D investment, tiered sales royalties, and a [...]
Patient-Led NM Launches Statewide Summits and Video Campaign to Spotlight New Mexico’s Healthcare Crisis
01/10/2025
A Call for New Mexicans to Demand Policy Reform That Secures Timely Access to High-Quality Care Santa Fe, NM, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Patient-Led NM today announced the launch of a series of Healthcare [...]
SilverSneakers® Celebrates Members Anne H. Thibodeaux and Cecilia Gomez as 2025 Members of the Year
30/09/2025
National awards recognize SilverSneakers members who motivate others by demonstrating a commitment to live active, healthy lifestyles. NASHVILLE, Tenn., Sept. 30, 2025 (GLOBE NEWSWIRE) -- SilverSneakers, one of the [...]
The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer
30/09/2025
- CMO with extensive experience in brand building, franchising and strategic growth – SCOTTSDALE, Ariz., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic [...]
Amneal to Report Third Quarter 2025 Results on October 30, 2025
30/09/2025
BRIDGEWATER, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its third [...]
Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President
30/09/2025
NOVATO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the appointment of Eric Olson as chief business officer (CBO) and executive vice president effective [...]
Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025
30/09/2025
TARRYTOWN, N.Y., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its third quarter 2025 financial and operating results on Tuesday, October 28, 2025 [...]
NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025
30/09/2025
PARIS et CAMBRIDGE, Mass., 30 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results
30/09/2025
PARIS and CAMBRIDGE, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand [...]
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
30/09/2025
Ad hoc announcement pursuant to Art. 53 LR Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment 1 Well-controlled disease observed as [...]
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/09/2025
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported [...]
The Beauty Health Company Names Pedro Malha President and Chief Executive Officer
30/09/2025
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., [...]
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
30/09/2025
TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
30/09/2025
Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) ( [...]
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF NOTE CONVERSION AGREEMENTS TO EXTINGUISH OVER TWO MILLION DOLLARS OF OUTSTANDING DEBT
30/09/2025
MINNEAPOLIS, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging [...]
AiM Medical Robotics Secures $8.1 Million Series A Financing to Transform Neurosurgery with MRI-Compatible Surgical Robotics
30/09/2025
— Financing round led by IQ Capital and 1540 Ventures accelerates path to first-in-human trials for groundbreaking robotic neurosurgical platform — WORCESTER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AiM Medical [...]
Evolution de la composition du Conseil d’administration
30/09/2025
Communiqué de presse Paris - Le 30 septembre 2025 - EUROAPI annonce aujourd’hui que conformément aux bonnes pratiques de gouvernance et à la suite de sa nomination en tant que directeur financier de Recipharm à compter [...]
Change in Board’s Composition
30/09/2025
Press Release Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1 st , 2025, [...]

Pages